These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18725877)

  • 1. Fighting fire with fire: effects of oncolytic virotherapy on underlying viral hepatitis in hepatocellular carcinoma.
    Reid T
    Mol Ther; 2008 Sep; 16(9):1521-3. PubMed ID: 18725877
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines.
    Choi SH; Park BK; Lee KW; Chang J; Lee Y; Kwon HJ
    BMB Rep; 2015 Oct; 48(10):565-70. PubMed ID: 25739391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
    Breitbach CJ; Arulanandam R; De Silva N; Thorne SH; Patt R; Daneshmand M; Moon A; Ilkow C; Burke J; Hwang TH; Heo J; Cho M; Chen H; Angarita FA; Addison C; McCart JA; Bell JC; Kirn DH
    Cancer Res; 2013 Feb; 73(4):1265-75. PubMed ID: 23393196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.
    Yoo SY; Badrinath N; Woo HY; Heo J
    Mediators Inflamm; 2017; 2017():5198798. PubMed ID: 28512387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.
    Moon J; Kaowinn S; Cho IR; Min DS; Myung H; Oh S; Kaewpiboon C; Kraemer OH; Chung YH
    Biochem Biophys Res Commun; 2016 Jun; 474(3):428-434. PubMed ID: 27150631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines.
    Song TJ; Eisenberg DP; Adusumilli PS; Hezel M; Fong Y
    J Gastrointest Surg; 2006 Apr; 10(4):532-42. PubMed ID: 16627219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatocellular carcinoma by AdAFPep/rep, AdAFPep/p53, and 5-fluorouracil in mice.
    Sagawa T; Yamada Y; Takahashi M; Sato Y; Kobune M; Takimoto R; Fukaura J; Iyama S; Sato T; Miyanishi K; Matsunaga T; Takayama T; Kato J; Sasaki K; Hamada H; Niitsu Y
    Hepatology; 2008 Sep; 48(3):828-40. PubMed ID: 18756484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of vaccinia JX594 from pustules following therapy for hepatocellular carcinoma.
    Kung CH; Kuo SC; Chen TL; Weng WS
    BMC Cancer; 2015 Oct; 15():704. PubMed ID: 26471278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The replicability of oncolytic virus: defining conditions in tumor virotherapy.
    Tian JP
    Math Biosci Eng; 2011 Jul; 8(3):841-60. PubMed ID: 21675814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer.
    Argnani R; Marconi P; Volpi I; Bolanos E; Carro E; Ried C; Santamaria E; Pourchet A; Epstein AL; Brocker T; Corrales FJ; Manservigi R; Goicoechea I; Foschini M; Hernandez-Alcoceba R
    Liver Int; 2011 Nov; 31(10):1542-53. PubMed ID: 22093330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.
    Samson A; Bentham MJ; Scott K; Nuovo G; Bloy A; Appleton E; Adair RA; Dave R; Peckham-Cooper A; Toogood G; Nagamori S; Coffey M; Vile R; Harrington K; Selby P; Errington-Mais F; Melcher A; Griffin S
    Gut; 2018 Mar; 67(3):562-573. PubMed ID: 27902444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma.
    Baril P; Touchefeu Y; Cany J; Cherel Y; Thorne SH; Tran L; Conchon S; Vassaux G
    J Gene Med; 2011 Dec; 13(12):692-701. PubMed ID: 22028274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic Activity of Sindbis Virus with the Help of GM-CSF in Hepatocellular Carcinoma.
    Shi X; Sun K; Li L; Xian J; Wang P; Jia F; Xu F
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.
    Altomonte J; Marozin S; De Toni EN; Rizzani A; Esposito I; Steiger K; Feuchtinger A; Hellerbrand C; Schmid RM; Ebert O
    Mol Ther; 2013 Nov; 21(11):2032-42. PubMed ID: 23939023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of virotherapy for effective tumor treatment.
    Garcia-Aragoncillo E; Hernandez-Alcoceba R
    Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.